e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Bronchiectasis and NTM infections: clinical aspects and research outlook
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
James D. Chalmers (Perth, United Kingdom), James Chalmers, Eva Polverino, Anthony De Soyza, Felix Ringshausen, Marlene Murris, Wim Boersma, Antoni Torres, Montserrat Vendrell, J. Stuart Elborn, Francesco Blasi, Stefano Aliberti, On Behalf of the EMBARC Clinical Research Collaboration
Source:
International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Session:
Bronchiectasis and NTM infections: clinical aspects and research outlook
Session type:
Poster Discussion
Number:
374
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
James D. Chalmers (Perth, United Kingdom), James Chalmers, Eva Polverino, Anthony De Soyza, Felix Ringshausen, Marlene Murris, Wim Boersma, Antoni Torres, Montserrat Vendrell, J. Stuart Elborn, Francesco Blasi, Stefano Aliberti, On Behalf of the EMBARC Clinical Research Collaboration. Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC). Eur Respir J 2015; 46: Suppl. 59, 374
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network
Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Year: 2015
Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Productivity losses in COPD – A population-based survey.
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
The Italian registry for severe/uncontrolled asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Regional distinctions regarding COPD prevalence in Russian Arctic: Results of national population study
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Ownership of written asthma action plans in a large Australian survey
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Asthma ICs prescriptions in primary care in France and the United Kingdom: Are they similar?
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Prevalence and incidence of bronchiectasis in Catalonia in 2012
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Clinico-pathological profile of adult bronchiectasis patients at a North Indian teaching hospital
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample
Source: International Congress 2014 – Epidemiology of asthma
Year: 2014
Bronchiectasis among hospitalised patients in Germany
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Differences in symptoms between patients with and without PCD: Data from a PCD diagnostic referral centre
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept